CD8A and neoplasm: Results showed that patients with a high proportion of tumor‐infiltrating CD8+ T cells had better overall survival than those with a low percentage of tumor‐infiltrating CD8+ T cells in the TCGA‐SKCM datasets (Figure 3A).